Aza-substituted spiro derivative

Details for Australian Patent Application No. 2006312557 (hide)

Owner MSD K.K.

Inventors Sato, Nagaaki; Tsukahara, Daisuke; Jitsuoka, Makoto

Agent Spruson & Ferguson

Pub. Number AU-B-2006312557

PCT Pub. Number WO2007/055418

Priority 2005-325808 10.11.05 JP; 2006-060814 07.03.06 JP

Filing date 10 November 2006

Wipo publication date 18 May 2007

Acceptance publication date 8 December 2011

International Classifications

C07D 491/107 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/4355 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 9/02 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/32 Drugs for disorders of the nervous system

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/055418 Priority application(s): WO2007/055418

24 March 2011 Assignment before Grant

  Banyu Pharmaceutical Co., Ltd. The application has been assigned to MSD K.K.

8 December 2011 Application Accepted

  Published as AU-B-2006312557

5 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006312562-Process for production of 2-(4-methyl-2-phenylpiperazin1-yl)pyridine-3-methanol

2006312544-Method of manufacturing electric resistance welding pipes having having excellent characterization of welded seams